Methods for assessing the preventability of adverse drug events: A systematic review

Drug Safety

Volumn 35, Issue 2, 2012, Pages 105-126

  Hakkarainen, Katja Marja ^a   Andersson Sundell, Karolina ^a   Petzold, Max ^a   Hägg, Staffan ^a,b  

^a NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adverse drug reactions; Medication errors

Indexed keywords

ADVERSE DRUG REACTION; ALGORITHM; CINAHL; CLINICAL ASSESSMENT; COCHRANE LIBRARY; EMBASE; HEALTH CARE; INSTRUMENT; MEDLINE; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; PILOT STUDY; PRIORITY JOURNAL; PSYCINFO; PUBLICATION; RELIABILITY; REVIEW; VALIDITY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG TOXICITY; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS;

EID: 84855861148     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11596570-000000000-00000     Document Type: Review

References (194)

1. de Vries EN, Ramrattan MA, Smorenburg SM, et al. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care 2008; 17 (3): 216-23
2. Masotti P, McColl MA, Green M. Adverse events experienced by homecare patients: a scoping review of the literature. Int J Qual Health Care 2010; 22 (2): 115-25
3. Morimoto T, Gandhi TK, Seger AC, et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004; 13 (4): 306-14 (Pubitemid 39070900)
4. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63 (2): 136-47 (Pubitemid 46072098)
5. Thomsen LA, Winterstein AG, Sondergaard B, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007; 41 (9): 1411-26 (Pubitemid 47311361)
6. Krahenbuhl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf 2007; 30 (5): 379-407 (Pubitemid 46740336)
7. Kanjanarat P, Winterstein AG, Johns TE, et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003; 60 (17): 1750-9 (Pubitemid 44717415)
8. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA 1995; 274 (1): 29-34
9. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995; 21 (10): 541-8
10. van Doormaal JE, Mol PG, van den Bemt PM, et al. Reliability of the assessment of preventable adverse drug events in daily clinical practice. Pharmacoepidemiol Drug Saf 2008; 17 (7): 645-54
11. Ferner RE,Aronson JK. Preventability of drug-related harms, part I: a systematic review. Drug Saf 2010; 33 (11): 985-94
12. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157 (14): 1531-6 (Pubitemid 27305197)
13. Even in best-run centers, preventable medication errors lengthen LOS, increase costs. Health Care Cost Reengineering Rep 1998; 3 (10): 149-51
14. Bell D. Cooperative approach to medication errors. Sth Hosp 1974; 42 (9): 12-20
15. Hulley SB, Martin JN, Cummings SR. Planning the measurement: precision and accuracy. In: Hulley SB, Cummings SR, Browner WS, et al., editors. Designing clinical research. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2007: 37-50
16. Streiner DL, Norman GR. Reliability. In: Streiner DL, Norman GR, editors. Health measurement scales-a practical guide to their development and use. 3rd ed. New York: Oxford University Press, 2003: 126-52
17. Streiner DL, Norman GR. Validity. In: Streiner DL, Norman GR, editors. Health measurement scales-a practical guide to their development and use. 3rd ed. New York: Oxford University Press, 2003: 173-93
18. van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008; 17 (4): 365-71 (Pubitemid 351566352)
19. Olivier P, Boulbes O, Tubery M, et al. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department. Drug Saf 2002; 25 (14): 1035-44 (Pubitemid 35397391)
20. Letrilliart L, Hanslik T, Biour M, et al. Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study. Drug Saf 2001; 24 (10): 781-92 (Pubitemid 32848356)
21. Calderon-Ospina C, Bustamante-Rojas C. The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients. Int J Pharm Pract 2010; 18 (4): 230-5
22. Farcas A, Sinpetrean A, Mogosan C, et al. Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania. Eur J Intern Med 2010; 21 (5): 453-7
23. Jö nsson AK, Hakkarainen KM, Spigset O, et al. Preventable drug related mortality in a Swedish population. Pharmacoepidemiol Drug Saf 2010; 19 (2): 211-5
24. Lopez LC, Botero M, Pino J, et al. Adverse drug reactions in internal medicine units at a university hospital: a descriptive pilot study. Colomb Medica 2010; 41 (1): 45-51
25. Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 2009; 4 (2): e4439
26. Pourseyed S, Fattahi F, Pourpak Z, et al. Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiol Drug Saf 2009; 18 (2): 104-10
27. Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 2008; 19 (7): 505-10
28. Al-Malaq HM, Al-Aqeel SA, Al-Sultan MS. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a university hospital in Riyadh. Saudi Med J 2008; 29 (8): 1145-50
29. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol 2008; 102 (4): 408-11 (Pubitemid 351393111)
30. Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31 (6): 545-56 (Pubitemid 351693687)
31. Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008; 30 (6): 854-62
32. Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf 2009; 18 (7): 639-45
33. Mehta U, Durrheim DN, Blockman M, et al. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol 2008; 65 (3): 396-406 (Pubitemid 351320492)
34. Ruiz B, Garcia M, Aguirre U, et al. Factors predicting hospital readmissions related to adverse drug reactions. Eur J Clin Pharmacol 2008; 64 (7): 715-22
35. Subish P, Mishra P, Shankar PR. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal. Pak J Pharm Sci 2008; 21 (4): 465-7
36. Grenouillet-Delacre M, Verdoux H, Moore N, et al. Lifethreatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med 2007; 33 (12): 2150-7 (Pubitemid 350164550)
37. Patel KJ, Kedia MS, Bajpai D, et al. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 2007; 7: 8
38. Rivkin A. Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm 2007; 64 (17): 1840-3 (Pubitemid 350202217)
39. Davies EC, Green CF, Mottram DR, et al. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31 (4): 335-41 (Pubitemid 44060196)
40. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61 (5): 511-5 (Pubitemid 43794712)
41. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006; 54 (3): 226-33 (Pubitemid 44119203)
42. Dormann H, Neubert A, Criegee-Rieck M, et al. Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 2004; 255 (6): 653-63 (Pubitemid 38703584)
43. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329 (7456): 15-9 (Pubitemid 38869995)
44. Temple ME, Robinson RF, Miller JC, et al. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 2004; 27 (11): 819-29 (Pubitemid 39243563)
45. Dormann H, Criegee-Rieck M, Neubert A, et al. Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003; 26 (5): 353-62 (Pubitemid 36433833)
46. Easton-Carter KL, Chapman CB, Brien JE. Adverse drug reactions in paediatrics: are we getting the full picture? J Pharm Res 2003; 33 (2): 106-10 (Pubitemid 37047295)
47. Easton-Carter KL, Chapman CB, Brien JE. Emergency department attendances associated with drug-related problems in paediatrics. J Paediatr Child Health 2003; 39 (2): 124-9 (Pubitemid 36308077)
48. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36 (9): 1331-6 (Pubitemid 34925265)
49. Wasserfallen J, Livio F, Buclin T, et al. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001; 12 (5): 442-7 (Pubitemid 32823524)
50. Lagnaoui R, Moore N, Fach J, et al. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 56 (2): 181-6 (Pubitemid 30341394)
51. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33 (2): 236-40 (Pubitemid 29109688)
52. Schumock GT, Seeger JD, Kong SX. Control charts to monitor rates of adverse drug reactions. Hosp Pharm 1995; 30 (12): 1088, 1091-2, 1095-6
53. Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51 (18): 2268-72 (Pubitemid 24293440)
54. Kramer MS, Hutchinson TA, Flegel KM, et al. Adverse drug reactions in general pediatric outpatients. J Pediatr 1985; 106 (2): 305-10 (Pubitemid 15130089)
55. Choonara IA, Harris F. Adverse drug reactions in medical inpatients. Arch Dis Child 1984; 59 (6): 578-80 (Pubitemid 14122095)
56. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993; 8 (6): 289-94 (Pubitemid 23177840)
57. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285 (16): 2114-20 (Pubitemid 32367829)
58. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348 (16): 1556-64 (Pubitemid 36437933)
59. Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm 2002; 59 (18): 1742-9 (Pubitemid 35033912)
60. Gray SL, Sager M, Lestico MR, et al. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998; 53 (1): M59-63 (Pubitemid 128763923)
61. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274 (1): 35-43
62. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277 (4): 307-11 (Pubitemid 27045011)
63. Cullen DJ, Sweitzer BJ, Bates DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25 (8): 1289-97 (Pubitemid 27347291)
64. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280 (15): 1311-6 (Pubitemid 28473716)
65. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5 (3): 305-14 (Pubitemid 28222037)
66. Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999; 159 (21): 2553-60
67. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999; 6 (4): 313-21 (Pubitemid 29328569)
68. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282 (3): 267-70 (Pubitemid 29343170)
69. Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001; 8 (3): 254-66 (Pubitemid 32428753)
70. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289 (9): 1107-16 (Pubitemid 37430324)
71. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52 (8): 1349-54 (Pubitemid 39038210)
72. Field TS, Gurwitz JH, Harrold LR, et al. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc 2004; 11 (6): 492-8 (Pubitemid 39421733)
73. Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care 2005; 43 (12): 1171-6 (Pubitemid 43012173)
74. Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med 2006; 34 (2): 415-25 (Pubitemid 43145621)
75. Field TS, Mazor KM, Briesacher B, et al. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc 2007; 55 (2): 271-6 (Pubitemid 46184405)
76. Kaushal R, Goldmann DA, Keohane CA, et al. Adverse drug events in pediatric outpatients. Ambul Pediatr 2007; 7 (5): 383-9 (Pubitemid 47387112)
77. Wang JK, Herzog NS, Kaushal R, et al. Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics 2007; 119 (1): e77-85 (Pubitemid 46397809)
78. Zandieh SO, Goldmann DA, Keohane CA, et al. Risk factors in preventable adverse drug events in pediatric outpatients. J Pediatr 2008; 152 (2): 225-31
79. Takata GS, Taketomo CK, Waite S, et al. Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative. Am J Health Syst Pharm 2008; 65 (21): 2036-44
80. Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health Syst Pharm 2004; 61 (14): 1466-72 (Pubitemid 39481418)
81. Franklin BD, Birch S, Schachter M, et al. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract 2010; 18 (5): 305-11
82. Hug BL, Witkowski DJ, Sox CM, et al. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med 2010; 25 (1): 31-8
83. Benkirane R, Pariente A, Achour S, et al. Prevalence and preventability of adverse drug events in a teaching hospital: a cross-sectional study. East Mediterr Health J 2009; 15 (5): 1145-55
84. Benkirane RR, Abouqal R, Haimeur CC, et al. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study. J Patient Saf 2009; 5 (1): 16-22
85. Kunac DL, Kennedy J, Austin N, et al. Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Paediatr Drugs 2009; 11 (2): 153-60
86. Gurwitz JH, Field TS, Rochon P, et al. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc 2008; 56 (12): 2225-33
87. Hwang SH, Lee S, Koo HK, et al. Evaluation of a computer-based adverse-drug-event monitor. Am J Health Syst Pharm 2008; 65 (23): 2265-72
88. Jha AK, Laguette J, Seger A, et al. Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Informatics Assoc 2008; 15 (5): 647-53
89. Kaushal R, Bates DW, Abramson EL, et al. Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients. AmJ Health Syst Pharm 2008; 65 (13): 1254-60 (Pubitemid 351898360)
90. Koneri R, Prakasam K, Mishra V, et al. Drug-related hospitalizations at a tertiary level hospital in Bangalore: a prospective study. J Clin Diagn Res 2008; 2 (2): 736-40 (Pubitemid 351594031)
91. Kunac DL, Reith DM. Preventable medication-related events in hospitalised children in New Zealand.NZ Med J 2008; 121 (1272): 17-32
92. Saha L, Pandhi P, Malhotra S, et al. Adverse Drug Event (ADE) related medical emergency department visits and hospital admissions: a prospective study from a north India referral India. J Clin Diagn Res 2008; 2 (1): 600-4 (Pubitemid 351279912)
93. Takata GS, Mason W, Taketomo C, et al. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals. Pediatrics 2008; 121 (4): e927-35
94. Tam KW, Kwok KH, Fan YM, et al. Detection and prevention of medication misadventures in general practice. Int J Qual Health Care 2008; 20 (3): 192-9 (Pubitemid 351753558)
95. Glassman PA, Belperio P, Lanto A, et al. The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc 2007; 14 (4): 424-31 (Pubitemid 46963041)
96. Holdsworth MT, Fichtl RE, Raisch DW, et al. Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients. Pediatrics 2007; 120 (5): 1058-66 (Pubitemid 350085540)
97. Queneau P, Bannwarth B, Carpentier F, et al. Emergency department visits caused by adverse drug events: results of a French survey. Drug Saf 2007; 30 (1): 81-8 (Pubitemid 46072360)
98. Seger AC, Jha AK, Bates DW. Adverse drug event detection in a community hospital utilising computerised medication and laboratory data. Drug Saf 2007; 30 (9): 817-24 (Pubitemid 47347354)
99. Kane-Gill S, Rea RS, Verrico MM, et al. Adverse-drugevent rates for high-cost and high-use drugs in the intensive care unit. Am J Health Syst Pharm 2006; 63 (19): 1876-81 (Pubitemid 44477460)
100. Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006; 184 (7): 321-4
101. Schade CP, Hannah K, Ruddick P, et al. Improving selfreporting of adverse drug events in a West Virginia hospital. Am J Med Qual 2006; 21 (5): 335-41 (Pubitemid 44342870)
102. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006; 166 (5): 565-71
103. Walsh KE, Adams WG, Bauchner H, et al. Medication errors related to computerized order entry for children. Pediatrics 2006; 118 (5): 1872-9 (Pubitemid 46393668)
104. Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother 2005; 39 (7-8): 1169-74 (Pubitemid 40943164)
105. Forster AJ, Murff HJ, Peterson JF, et al. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005; 20 (4): 317-23 (Pubitemid 40617599)
106. Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005; 118 (3): 251-8 (Pubitemid 40312636)
107. Mycyk MB, McDaniel MR, Fotis MA, et al. Hospital wide adverse drug events before and after limiting weekly work hours of medical residents to 80. Am J Health Syst Pharm 2005; 62 (15): 1592-5 (Pubitemid 41060471)
108. Weingart SN, Gandhi TK, Seger AC, et al. Patientreported medication symptoms in primary care. Arch Intern Med 2005; 165 (2): 234-40
109. Hardmeier B, Braunschweig S, Cavallaro M, et al. Adverse drug events caused by medication errors in medical inpatients. Swiss Med Wkly 2004; 134 (45-46): 664-70 (Pubitemid 40013129)
110. Holdsworth MT, Fichtl RE, Behta M, et al. Incidence and impact of adverse drug events in pediatric inpatients. Arch Pediatr Adolesc Med 2003; 157 (1): 60-5 (Pubitemid 36343419)
111. Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Pharmacother 2003; 37 (1): 5-11 (Pubitemid 36068590)
112. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31 (4): 199-205 (Pubitemid 32592646)
113. Jha AK, Kuperman GJ, Rittenberg E, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10 (2): 113-9 (Pubitemid 32590942)
114. Malhotra S, Jain S, Pandhi P. Drug-related visits to the medical emergency department: a prospective study from India. Int J Clin Pharmacol Ther 2001; 39 (1): 12-8 (Pubitemid 32048057)
115. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58 (12): 1126-32 (Pubitemid 32552897)
116. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109 (2): 87-94
117. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54 (12): 959-63 (Pubitemid 29104418)
118. Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10 (4): 199-205
119. Thomas EJ, Orav EJ, Brennan TA. Hospital ownership and preventable adverse events. Int J Health Serv 2000; 30 (4): 745-61
120. Buckley MS, Erstad BL, Kopp BJ, et al. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit. Pediatr Crit Care Med 2007; 8 (2): 145-52 (Pubitemid 46568564)
121. Ligi I, Arnaud F, Jouve E, et al. Iatrogenic events in admitted neonates: a prospective cohort study. Lancet 2008; 371 (9610): 404-10 (Pubitemid 351181335)
122. Leape LL, Lawthers AG, Brennan TA, et al. Preventing medical injury. QRB Qual Rev Bull 1993; 19 (5): 144-9
123. Forster AJ, Murff HJ, Peterson JF, et al. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003; 138 (3): 161-7 (Pubitemid 36231621)
124. Agarwal S, Classen D, Larsen G, et al. Prevalence of adverse events in pediatric intensive care units in the United States. Pediatr Crit Care Med 2010; 11 (5): 568-78
125. Mercier E, Giraudeau B, Ginies G, et al. Iatrogenic events contributing to ICU admission: a prospective study. Intensive Care Med 2010; 36 (6): 1033-7
126. Aranaz-Andres J, Aibar-Remon C, Vitaller-Murillo J, et al. Incidence of adverse events related to health care in Spain: Results of the Spanish National Study of Adverse Events. J Epidemiol Community Health 2008; 62 (12): 1022-9
127. Michel P, Quenon JL, Djihoud A, et al. French national survey of inpatient adverse events prospectively assessed with ward staff. Qual Saf Health Care 2007; 16 (5): 369-77 (Pubitemid 47612677)
128. Sari AB, Sheldon TA, Cracknell A, et al. Extent, nature and consequences of adverse events: results of a retrospective casenote review in a large NHS hospital. Qual Saf Health Care 2007; 16 (6): 434-9
129. Woods DM, Holl JL, Klein JD, et al. Patient safety problems in adolescent medical care. J Adolesc Health 2006; 38 (1): 5-12 (Pubitemid 43016148)
130. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005; 33 (8): 1694-700 (Pubitemid 41153692)
131. Woods D, Thomas E, Holl J, et al. Adverse events and preventable adverse events in children. Pediatrics 2005; 115 (1): 155-60 (Pubitemid 43046294)
132. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals, II: preventability and clinical context. N Z Med J 2003; 116 (1183): U624
133. Darchy B, Le Miere E, Figueredo B, et al. Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 1999; 159 (1): 71-8 (Pubitemid 29044122)
134. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228 (2): 83-90 (Pubitemid 20257272)
135. Hallas J, Harvald B, Worm J, et al. Drug related hospital admissions: results from an intervention program. Eur J Clin Pharmacol 1993; 45 (3): 199-203 (Pubitemid 23290367)
136. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33 (1): 61-8
137. Hoonhout LHF, De Bruijne MC, Wagner C, et al. Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands. Drug Saf 2010; 33 (10): 853-64
138. Pattanaik S, Dhamija P, Malhotra S, et al. Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study. Br J Clin Pharmacol 2009; 67 (3): 363-9
139. Rogers S, Wilson D, Wan S, et al. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging 2009; 26 (11): 951-61
140. Al-Olah YH, Al Thiab KM. Admissions through the emergency department due to drug-related problems. Ann Saudi Med 2008; 28 (6): 426-9
141. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168 (17): 1890-6
142. Witherington EMA, Pirzada OM, Avery AJ. Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study. Qual Saf Health Care 2008; 17 (1): 71-5 (Pubitemid 351262956)
143. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008; 178 (12): 1563-9 (Pubitemid 351860342)
144. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007; 34 (5-6): 494-8 (Pubitemid 46494476)
145. Baena MI, Faus MJ, Fajardo PC, et al. Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol 2006; 62 (5): 387-93
146. Samoy LJ, Zed PJ, Wilbur K, et al. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy 2006; 26 (11): 1578-86 (Pubitemid 44704470)
147. Easton KL, Chapman CB, Brien JA. Frequency and characteristics of hospital admissions associated with drugrelated problems in paediatrics. Br J Clin Pharmacol 2004; 57 (5): 611-5 (Pubitemid 38582181)
148. Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12 (4): 280-5 (Pubitemid 36981325)
149. Koh Y, Fatimah BM, Li SC. Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci 2003; 25 (4): 135-7 (Pubitemid 36987783)
150. Ng D, Cosh DG, Harris J, et al. Unplanned medicationrelated admissions to an acute care general teaching hospital. Aust J Hosp Pharm 1999; 29 (2): 84-7
151. Tafreshi MJ, Melby MJ, Kaback KR, et al. Medicationrelated visits to the emergency department: a prospective study. Ann Pharmacother 1999; 33 (12): 1252-7 (Pubitemid 30022801)
152. Easton KL, Parsons BJ, Starr M, et al. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169 (7): 356-9 (Pubitemid 28486781)
153. Cunningham G, Dodd TR, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26 (5): 375-82 (Pubitemid 27448382)
154. Dartnell JG, Anderson RP, Chohan V, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164 (11): 659-62 (Pubitemid 26172599)
155. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health Syst Pharm 1996; 53 (12): 1422-6 (Pubitemid 26186032)
156. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16 (4): 701-7 (Pubitemid 26285928)
157. Courtman BJ, Stallings SB. Characterization of drugrelated problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995; 48 (3): 161-6
158. Hallas J, Worm J, Beck-Nielsen J, et al. Drug related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991; 38 (5): 417-20
159. Dubois RW, Brook RH. Preventable deaths: who, how often, and why? Ann Intern Med 1988; 109 (7): 582-9
160. Hiatt HH, Barnes BA, Brennan TA, et al. A study of medical injury and medical malpractice. N Engl J Med 1989; 321 (7): 480-4
161. Wilson RM, Runciman WB, Gibberd RW, et al. The Quality in Australian Health Care Study. Med J Aust 1995; 163 (9): 458-71
162. Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals: principal findings from a national survey-occasional paper no 3. Wellington: Ministry of Health, 2001
163. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47 (3): 533-43 (Pubitemid 20138134)
164. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27 (6): 538
165. Imbs JL, Pletan Y, Spriet A. Assessment of preventable iatrogenic drug therapy: methodology-round table no. 2 at Giens XIII [in French]. Therapie 1998; 53 (4): 365-70
166. Livio F, Buclin T, Yersin B, et al. Hospitalisations pour effet indé sirable mé dicamenteux. Raison de Santé No. 23. Lausanne: Hospices Cantonaux, 1998
167. Baena MI, Marin R, Martinez-Olmos J, et al. New criteria of assessing preventability of drug-related problems: an updated review based on the experience with 2558 people [in Spanish]. Pharm Care Esp 2002; 4: 393-6 (Pubitemid 36032878)
168. Lau PM, Stewart K, Dooley MJ. Comment: hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2003; 37 (2): 303-4
169. Olivier P, Caron J, Haramburu F, et al. Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale [in French]. Therapie 2005; 60 (1): 39-45 (Pubitemid 40469309)
170. Zegers M, de Bruijne MC, Wagner C, et al. The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record. J Clin Epidemiol 2010; 63 (1): 94-102
171. Kunac DL, Reith DM, Kennedy J, et al. Inter-and intrarater reliability for classification of medication related events in paediatric inpatients. Qual Saf Health Care 2006; 15 (3): 196-201
172. Michel P, Quenon JL, de Sarasqueta AM, et al. Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. BMJ 2004; 328 (7433): 199
173. Thomas EJ, Lipsitz SR, Studdert DM, et al. The reliability of medical record review for estimating adverse event rates. Ann Intern Med 2002; 136 (11): 812-6 (Pubitemid 34568651)
174. Altman DG. Some common problems in medical research. In: Altman DG, editor. Practical statistics for medical research. 1st ed. Boca Raton (FL): Chapman & Hall/CPC, 1991: 396-439
175. Snyder RA, Abarca J, Meza JL, et al. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index. Pharmacoepidemiol Drug Saf 2007; 16 (9): 1006-13 (Pubitemid 47422850)
176. Hayward RA, Hofer TP. Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA 2001; 286 (4): 415-20 (Pubitemid 32681483)
177. Caplan RA, Posner KL, Cheney FW. Effect of outcome on physician judgments of appropriateness of care. JAMA 1991; 265 (15): 1957-60
178. Aronson JK, Ferner RE. Preventability of drug-related harms-part II: proposed criteria, based on frameworks that classify adverse drug reactions. Drug Saf 2010; 33 (11): 995-1002
179. Streiner DL, Norman GR. Scaling responses. In: Streiner DL, Norman GR, editors. Health measurement scales-a practical guide to their development and use. 3rd ed. New York: Oxford University Press, 2003: 29-60
180. Brennan TA, Localio RJ, Laird NL. Reliability and validity of judgments concerning adverse events suffered by hospitalized patients. Med Care 1989; 27 (12): 1148-58
181. Bryant GD, Norman GR. Expressions of probability: words and numbers. N Engl J Med 1980; 302 (7): 411
182. Williams SD, Ashcroft DM. Medication errors: how reliable are the severity ratings reported to the national reporting and learning system? Int J Qual Health Care 2009; 21 (5): 316-20
183. Localio AR, Weaver SL, Landis JR, et al. Identifying adverse events caused by medical care: degree of physician agreement in a retrospective chart review. Ann Intern Med 1996; 125 (6): 457-64 (Pubitemid 126690037)
184. Hofer TP, Bernstein SJ, DeMonner S, et al. Discussion between reviewers does not improve reliability of peer review of hospital quality. Med Care 2000; 38 (2): 152-61
185. MacKenzie EJ, Steinwachs DM, Bone LR, et al. Interrater reliability of preventable death judgments. The Preventable Death Study Group. J Trauma 1992; 33 (2): 292-302
186. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4 (10): e297
187. International Society for Pharmacoepidemiology (ISPE). Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 2008; 17 (2): 200-8
188. Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf 2006; 29 (11): 1011-22 (Pubitemid 44912710)
189. World Health Organization. WHO patient safety research: better knowledge for safer care. Geneva: World Health Organization, 2009
190. Expert Group on Safe Medication Practices. Creation of a better medication safety culture in Europe: building up safe medication practices. Strasbourg: Council of Europe, 2006
191. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. EMA/489873/2008: ENCePP code of conduct for scientific independence and transparency in the conduct of pharmacoepidemiological and pharmacovigilance studies. London: European Medicines Agency, 2010
192. World Health Organization.World alliance for patient safety: forward programme 2008-2009. 1st ed. Geneva: World Health Organization, 2008
193. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356 (9237): 1255-9
194. Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring: cost and benefit considerations, part II-cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6 Suppl. 3: S79-90 (Pubitemid 27483544)